Feedback / Questions
camidanlumab tesirine (ADCT-301) - Genmab, ADC Therapeutics
Zynlonta (loncastuximab tesirine) - Overland ADCT BioPharma, Mitsubishi Tanabe
https://www.businesswire.com/news/home/20220512005635/en/ADC-Therapeutics-Announces-Abstracts-to-be-Presented-at-the-European-Hematology-Association-2022-Hybrid-Congress
May 12, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next